DRGYX
Price
$49.40
Change
-$0.42 (-0.84%)
Updated
Sep 12 closing price
Net Assets
9.1B
RMFCX
Price
$61.18
Change
-$0.20 (-0.33%)
Updated
Sep 12 closing price
Net Assets
110.3B
Interact to see
Advertisement

DRGYX vs RMFCX

Header iconDRGYX vs RMFCX Comparison
Open Charts DRGYX vs RMFCXBanner chart's image
BNY Mellon Dynamic Value Fund Y
Price$49.40
Change-$0.42 (-0.84%)
VolumeN/A
Net Assets9.1B
American Funds American Mutual R3
Price$61.18
Change-$0.20 (-0.33%)
VolumeN/A
Net Assets110.3B
DRGYX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DRGYX vs. RMFCX commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRGYX is a Hold and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. DRGYX (9.1B). RMFCX pays higher dividends than DRGYX: RMFCX (1.24) vs DRGYX (1.08). DRGYX was incepted earlier than RMFCX: DRGYX (12 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than DRGYX (0.64). DRGYX is a more actively managed with annual turnover of: 90.65 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than DRGYX: RMFCX (250) vs DRGYX (1000000). RMFCX annual gain was more profitable for investors over the last year : 7.96 vs. DRGYX (6.19). RMFCX return over 5 years is better than : 60.22 vs. DRGYX (54.60).
DRGYXRMFCXDRGYX / RMFCX
Total Expense Ratio0.640.9170%
Annual Report Gross Expense Ratio0.640.9170%
Fund Existence12 years23 years-
Gain YTD11.53812.76790%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.1B110B8%
Annual Yield % from dividends1.081.2487%
Returns for 1 year6.197.9678%
Returns for 3 years24.8032.8775%
Returns for 5 years54.6060.2291%
Returns for 10 years37.2093.4840%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRTA4.300.09
+2.14%
Strata Critical Medical Inc
ABLLL25.100.05
+0.20%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028
TILE28.52-0.12
-0.42%
Interface
CUE0.74-0.02
-3.16%
Cue Biopharma
GAP22.90-1.33
-5.49%
Gap Inc (The)